Literature DB >> 758994

Clinicopathologic findings in 52 patients studied by technetium-99m stannous pyrophosphate myocardial scintigraphy.

L R Poliner, L M Buja, R W Parkey, F J Bonte, J T Willerson.   

Abstract

Scintigraphic, clinical and pathological findings were correlated in 52 patients studied by technetium-99m stannous pyrophosphate (99mTc-PYP) myocardial scintigraphy before death or surgical resection of myocardium. Fifty-nine clinical events were studied with scintigraphy in the 52 patients; 41 of the 59 were associated with one or more abnormal 99mTc-PYP studies and 18 with normal 99mTc-PYP scintigrams. Myocardial scintigrams were positive in 29 of 31 cases with clinicopathological evidence of a corresponding discrete, grossly obvious acute myocardial infarct, including 16 of 16 transmural myocardial infarcts and 13 of 15 subendocardial infarcts. In 16 of 18 cases, negative myocardial scintigrams correlated with the absence of acute myocardial infarction determined by clinicopathological evidence. In two cases small subendocardial infarcts (less than 3 g) were not detected by 99mTc-PYP myocardial scintigraphy. Of the 12 additional instances of positive 99mTc-PYP myocardial scintigrams, five were associated with clinical unstable angina pectoris and seven were in the category of persistently positive scintigrams, since the scans were obtained 2.5 months or longer after proven or suspected acute myocardial infarcts. In all 12 instances, the positive 99mTc-PYP scintigrams were associated with evidence of multifocal irreversible myocardial damage consisting of myocytolysis, coagulation necrosis and/or fibrosis, and the histological age of the lesions was compatible with acute injury corresponding to the time of scintigraphy. The findings indicate that a positive 99mTc-PYP myocardial scintigram is a sensitive indicator of significant myocardial injury which may occur as confluent coagulation necrosis corresponding to clinical acute myocardial infarction, or as multifocal coagulation necrosis or myocytolysis associated with unstable angina pectoris or recurrent ischemic heart disease, especially after previous infarctions.

Entities:  

Mesh:

Substances:

Year:  1979        PMID: 758994     DOI: 10.1161/01.cir.59.2.257

Source DB:  PubMed          Journal:  Circulation        ISSN: 0009-7322            Impact factor:   29.690


  6 in total

1.  Nuclear medicine-epitomes of progress: detection of acute myocardial infarction by pyrophosphate tc scintigraphy.

Authors:  K P Lyons; H Olson
Journal:  West J Med       Date:  1981-05

2.  Nonperfusion applications in nuclear cardiology: report of a task force of the American Society of Nuclear Cardiology.

Authors:  E G DePuey; S Port; F J Wackers; A Rozanski; E H Botvinick; M W Dae; N Tamaki
Journal:  J Nucl Cardiol       Date:  1998 Mar-Apr       Impact factor: 5.952

3.  Underestimation of equilibrium radionuclide left ventricular ejection fraction due to myocardial uptake of 99mTc.

Authors:  P F Hoilund-Carlsen; J Marving
Journal:  Eur J Nucl Med       Date:  1984

4.  Subendocardial ischemic myocardial lesions associated with severe coronary atherosclerosis.

Authors:  J C Geer; C A Crago; W C Little; L L Gardner; S P Bishop
Journal:  Am J Pathol       Date:  1980-03       Impact factor: 4.307

5.  Combined thallium 201/technetium 99m-labeled pyrophosphate tomography for identification of the "culprit" vessel in acute myocardial infarction.

Authors:  T Krause; A Zeiher; W Kasper; M Schwehn; C Schümichen; E Moser
Journal:  J Nucl Cardiol       Date:  1996 Mar-Apr       Impact factor: 5.952

6.  Localization of In-111 antimyosin Fab and 99mTc-pyrophosphate in reperfusion myocardial infarction model.

Authors:  D S Lee; M C Lee; J K Chung; C S Koh; D H Moon
Journal:  Korean J Intern Med       Date:  1990-01       Impact factor: 2.884

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.